HGH serum testing

mands

Elite
AnabolicLab.com Supporter
10+ Year Member
20+ Year Member
Guys,

If I were to draw blood to get a GH serum level test would I or would I not fast the night before. I think there is like a three hour window to draw blood as well after injection.

Does anyone have any thoughts on this?

mands
 
NOBODY!!! Dr. Scally, Bill, Millard, DrJim, RG...... Anyone! I know I'm impatient.

mands
 
Why are you getting A Gh test? A spot GH test is worthless, for the most part. having said that, it would be best to fast.


GH Secretion after Glucose Ingestion in Men

In clinical studies, a rebound-like pattern of GH release begins several hours after oral glucose administration [oral glucose tolerance test (OGTT)]. A similar time delay applies to exogenous glucagon-induced GH release, which also transiently elevates blood glucose concentrations. The mechanisms that control delayed rebound- like GH secretion after glucose ingestion are not known.

GH secretion is supervised by an ensemble of hypothalamic peptides and systemic hormones. Somatostatin is a noncompetitive inhibitor of GH release, whereas GHRH stimulates both GH synthesis and secretion. The GH-releasing peptide (GHRP), ghrelin, amplifies the amount of GH secreted per burst. GHRP’s primary action in vivo is via the regulation of GHRH and somatostatin, although strong GH release is observable in vitro also in primary primate pituitary cell cultures.

Systemic hormones and metabolites may modulate GH secretion directly at the pituitary level and/or indirectly by modifying the release and actions of somatostatin, GHRH, or ghrelin. For example, in the rat, hyperglycemia evokes somatostatin-dependent inhibition of pulsatile GH secretion. In humans, oral glucose administration also suppresses GH concentrations rapidly and markedly inferentially by inhibition of hypothalamic GHRH and/or the stimulation of somatostatin release because GHRP attenuates the inhibitory effect of glucose ingestion.

Suppression of GH release by glucose or somatostatin is followed by rebound-like secretion, resulting in peak GH concentrations above the fasting baseline values. The mechanisms mediating postsomatostatin rebound-like GH peak may include GHRH release and somatostatin withdrawal, which triggers discharge of newly synthesized GH granules.

10051-hgh-serum-testing-gh-glucose.gif



Iranmanesh A, Lawson D, Veldhuis JD. Distinct Metabolic Surrogates Predict Basal and Rebound GH Secretion after Glucose Ingestion in Men. Journal of Clinical Endocrinology & Metabolism. Distinct Metabolic Surrogates Predict Basal and Rebound GH Secretion after Glucose Ingestion in Men

Context: GH secretion declines rapidly after glucose ingestion and then recovers to higher-than-baseline levels (rebound GH release).Hypothesis: Selective metabolic markers predict the magnitude of glucose-suppressed GH release and postglucose rebound-like GH secretion.

Design: Prospectively randomized crossover study of GH secretion after glucose vs. water ingestion.

Setting: The study was conducted at a clinical translational research center.Participants: Sixty-nine healthy men aged 19–78 yr with a body mass index of 18-39 kg/m2 participated in the study.

Outcomes: Outcomes included nadir vs. peak GH concentrations and basal vs. pulsatile GH secretion.Results: Mean nadir GH concentrations were determined positively by sex hormone binding globulin (SHBG) after glucose administration (R2 = 0.088, P = 0.0077). Peak rebound GH concentrations were related positively to adiponectin and negatively to computed tomography-estimated abdominal visceral fat (AVF) (R2 = 0.182, P = 0.00049) after glucose ingestion. Deconvolution analysis showed that SHBG specifically predicted basal (nonpulsatile) GH secretion after glucose exposure (R2 = 0.153, P = 0.00052). In contrast, together exercise history and adiponectin (both positively) and AVF (negatively) predicted pulsatile GH escape after glucose suppression (R2 = 0.206, P = 0.00043). Moreover, adiponectin uniquely determined the size (mass), and AVF the mode (duration), of GH secretory bursts after glucose exposure (both P < 0.006).

Conclusion: Glucose ingestion provides a clinical model for investigating complementary metabolic surrogates that determine suppression and recovery of basal and pulsatile GH secretion in healthy men.
 

Attachments

  • GH-Glucose.gif
    GH-Glucose.gif
    89.9 KB · Views: 70
Last edited:
Why are you getting A Gh test? A spot GH test is worthless, for the most part. having said that, it would be best to fast.

I was thinking I could test my GH serum levels after injecting 10 iu's of a certain brand of GH and have blood drawn within three hours of injecting to show legitimacy of that GH being tested. I figured it would be a better indication than IGF-1 levels being tested. Couldn't a person trying to fake GH use IGF-1 and therefore testing GH serum levels you could count this out?

Am I way off base here?

mands
 
I was thinking I could test my GH serum levels after injecting 10 iu's of a certain brand of GH and have blood drawn within three hours of injecting to show legitimacy of that GH being tested. I figured it would be a better indication than IGF-1 levels being tested. Couldn't a person trying to fake GH use IGF-1 and therefore testing GH serum levels you could count this out?

Am I way off base here?

mands

i have seen hgh serum testing for this purpose. good question. does it work and how to time it. is there predictable response for 2iu, 4ius, 10 ius....
 
i have seen hgh serum testing for this purpose. good question. does it work and how to time it. is there predictable response for 2iu, 4ius, 10 ius....

Not sure on that one either! Also, why fast if you are checking synthetic GH? And would you inject IM or SubQ? Will IM raise your serum levels faster and more so than subq?

mands
 
See Table 6 & Figure 1: HUMATROPE (SOMATROPIN) KIT [ELI LILLY AND COMPANY]


Also, see:

Brearley C, Priestley A, Leighton-Scott J, Christen M. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle. BMC Clin Pharmacol 2007;7:10. BMC Clinical Pharmacology | Full text | Pharmacokinetics of recombinant human growth hormone administered by cool.click (TM) 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle

BACKGROUND: Growth hormone (GH) is used to treat growth hormone deficiency (GHD, adult and paediatric), short bowel syndrome in patients on a specialized diet, HIV-associated wasting and, in children, growth failure due to a number of disorders including Turner's syndrome and chronic renal failure, and in children born small for gestational age. Different brands and generic forms of recombinant human growth hormone (r-hGH) are approved for varying indications in different countries. New ways of administering GH are required because the use of a needle and syringe or a device where a patient still has to insert the needle manually into the skin on a daily basis can lead to low adherence and sub-optimal treatment outcomes. The objective of this study was to assess the relative bioavailability of r-hGH (Saizen, Merck Serono) administered by a new needle-free device, cool.click 2, and a standard needle and syringe.

METHODS: The study was performed with 38 healthy volunteers who underwent pituitary somatotrope cell down-regulation using somatostatin, according to a randomized, two-period, two-sequence crossover design. Following subcutaneous administration of r-hGH using cool.click 2 or needle and syringe, pharmacokinetic parameters were analysed by non-compartmental methods. Bioequivalence was assessed based on log-transformed AUC and C(max) values.

RESULTS: The 90% confidence intervals for test/reference mean ratio of the plasma pharmacokinetic variables Cmax and AUC(0-inf) were 103.7-118.3 and 97.1-110.0, respectively, which is within the accepted bioequivalence range of 80-125%. r-hGH administered by cool.click 2 is, therefore, bioequivalent to administration by needle and syringe with respect to the rate and extent of GH exposure. Treatment using cool.click 2 was found to be well tolerated. With cool.click 2 the tmax was less (3.0 hours) than for needle and syringe delivery (4.5 hours), p = 0.002 (Friedman test), although this is unlikely to have any clinical implications.

CONCLUSION: These results demonstrate that cool.click 2 delivers subcutaneous r-hGH exposure that is bioequivalent to the conventional mode of injection. The new device has the additional advantage of being needle-free, and should help to increase patient adherence and achieve good therapeutic outcomes from r-hGH treatment.
 
Last edited:
Thanks for the find Dr. Scally. I did not read anything about fasting. I could of missed it. What about your personal thoughts on my testing theory. Am I off my rocker?

mands

Bump Dr. Scally or others. Is my theory sound or bunk?

mands
 
Is the purpose of the test to try to see if GH levels are very high after having taken a suspected product?

If so, then I suppose fast the night before and have carbs shortly before the blood draw, to minimize contribution from natural GH.

Or, if this is a qualitative test -- bunk or not? -- then I'd think that injecting 4 IU would answer that question no matter whether you'd fasted or not.
 
What would I suspect to to see from injecting 4 iu's of legit HGH? Serum level around 15 or so?

mands
 
I don't know, I've never tried it. Certainly many times physiological.

The injection should be very promptly before the draw. Basically, if there will be a wait time, I'd do it in the parking lot. But if expected to be only a few minutes wait time, perhaps 15 minutes before the expected time of drawing.

GH has a very short half-life.
 
Although I'm not saying that if you inject 4 IU it's going to be all gone in 15 minutes! By no means. I suppose levels stay supraphysiological for quite some time. But still, having the measurement close to the time of injection would result in a reading closer to what the peak value was, and even small differences in time such as 15 minutes would affect that.
 
Sounds reasonable I think. I would also think being synthetic the rise in serum levels would be elevated for a few hours at least. The graph Dr. Scally posted seems to show this. IV injection seemed to drop a lot faster. Thanks for all the input. I have a couple Chinese HGH in question and I think this would be a good test for legitimacy.

mands
 
I've done a little reading on this but can't seem to find the answer.

If rHGH, once reconstituted, degrades slowly over time at room temperature, then why wouldn't it degrade in the blood sample (at 98F) taken at the blood draw lab? Often blood samples are not tested for many hours and sometimes even days after blood is drawn so it seems that the GH would no longer be active in the blood unless the test were performed immediately. My understanding is that GH binds only to peripheral tissue and doesn't bind to anything in the blood, so what am I missing?
 
I've done a little reading on this but can't seem to find the answer.

If rHGH, once reconstituted, degrades slowly over time at room temperature, then why wouldn't it degrade in the blood sample (at 98F) taken at the blood draw lab? Often blood samples are not tested for many hours and sometimes even days after blood is drawn so it seems that the GH would no longer be active in the blood unless the test were performed immediately. My understanding is that GH binds only to peripheral tissue and doesn't bind to anything in the blood, so what am I missing?

You are correct by stating that GH would no longer be active because of short half-life. When checking HGH serum levles or IGF-1 levels in the blood you are not testing for actual "GH"! You are checking HGH serum levles or IGF-1 levels in the blood and these can be elevated for hours after administering your GH.

Not sure if I explained this correctly. Anyone care to jump in and elaborate if I did not.

mands
 
I found out the answer and it's pretty much like you said.

What degrades over time is the bioavailability of the GH, ie. it's mechanism of action when administered. It's still GH but it would no longer have any effect.
 
Back
Top